Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what progress his department has made in implementing the Advisory Council on the Misuse of Drugs recommendation to reduce barriers to research into promising treatments for cluster headaches.

The Department of Health and Social Care is working with officials in the Home Office to support the changes agreed to in the letter from the Minister of State at the Department for Work and Pensions and the Parliamentary Under-Secretary of State for Patient Safety, Women’s Health and Mental Health from July 2025. The group has met with stakeholders from the clinical trials community who gave advice and assurance on the proposed changes to the legislation.

The Department is committed to turbocharging clinical research and delivering better patient care, to make the United Kingdom a world-leading destination for clinical research. We are working to fast-track clinical trials, reducing barriers and unnecessary bureaucracy to drive global investment into life sciences, improve health outcomes, and accelerate the development of the medicines and therapies of the future, including treatments for cluster headaches. We expect these efforts to attract more commercial investment in clinical research and to yield a broad and diverse portfolio of clinical trials in the UK.

The Department is committed to ensuring that all patients, including those with cluster headaches, have access to cutting-edge clinical trials and innovative, lifesaving treatments.